BRIEF published on 05/08/2026 at 06:35, 1 month 15 days ago Lonza Reports Strong Q1 2026 Performance, Affirms Annual Outlook Operational Expansion CDMO Growth Divestment Strategy Lonza Q1 2026 Geopolitical Resilience
PRESS RELEASE published on 05/08/2026 at 06:30, 1 month 15 days ago Lonza Delivers Strong Performance in Q1 2026 in Line with Expectations and Confirms Full-Year Outlook 2026 Lonza delivers strong performance in Q1 2026, confirms outlook for the year. Completes transformation to a pure-play CDMO CDMO Lonza Outlook Transformation Q1 2026
BRIEF published on 04/01/2026 at 06:35, 2 months 22 days ago Lonza annonce les détails de son assemblée générale annuelle 2026 et publie ses rapports 2025. Proposition De Dividende Changements Au Conseil D'administration Efforts De Développement Durable Rapport Annuel 2025 Assemblée Générale Annuelle De 2026
BRIEF published on 04/01/2026 at 06:35, 2 months 22 days ago Lonza Announces 2026 AGM Details and Publishes 2025 Reports Board Changes Dividend Proposal Sustainability Efforts 2025 Annual Report 2026 AGM
PRESS RELEASE published on 04/01/2026 at 06:30, 2 months 22 days ago Lonza Publishes 2026 Annual General Meeting Invitation and 2025 Annual and Sustainability Reports Lonza publishes 2026 AGM invitation and 2025 Annual and Sustainability Reports. Board changes and dividend increase announced Dividend Increase Lonza Annual Report Sustainability Report 2026 AGM
BRIEF published on 03/31/2026 at 14:05, 2 months 22 days ago Lonza Nominates Stephen Fry as Independent Board Member Pharmaceutical Industry Governance Organizational Transformation Lonza Board Stephen Fry
BRIEF published on 03/31/2026 at 14:05, 2 months 22 days ago Lonza nomme Stephen Fry membre indépendant du conseil d'administration Gouvernance Industrie Pharmaceutique Transformation Organisationnelle Conseil D'administration De Lonza Stephen Fry
PRESS RELEASE published on 03/31/2026 at 14:00, 2 months 22 days ago Lonza Nominates Stephen Fry as Independent Board Member Lonza nominates Stephen Fry, with extensive pharma industry track record, as Independent Board Member. Fry to join Lonza AGM in May 2026 Lonza AGM Board Member Pharma Industry Stephen Fry
BRIEF published on 03/09/2026 at 14:05, 3 months 13 days ago Lonza and Genetix Extend Manufacturing Agreement for ZYNTEGLO™ Lonza Gene Therapy Manufacturing Agreement Genetix ZYNTEGLO™
BRIEF published on 03/09/2026 at 14:05, 3 months 13 days ago Lonza et Genetix prolongent leur accord de fabrication pour ZYNTEGLO™ Lonza Thérapie Génique Accord De Fabrication ZYNTEGLO™ Génétique
Published on 06/23/2026 at 09:05, 1 hour 12 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 06:45, 3 hours 32 minutes ago CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds
Published on 06/23/2026 at 06:45, 3 hours 32 minutes ago La confiance des CTO dans le déploiement à grande échelle de l'IA recule pour la troisième année consécutive
Published on 06/23/2026 at 06:01, 4 hours 16 minutes ago Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
Published on 06/23/2026 at 01:55, 8 hours 22 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/23/2026 at 10:05, 12 minutes ago Rockwell Automation Announces Cranswick to Improve Production-Line Efficiency with Precision Robotic Pick-and-Place Technology
Published on 06/23/2026 at 10:05, 12 minutes ago ADIPEC 2026 Technical Conferences attract record submissions in response to rising demand and energy security pressures
Published on 06/23/2026 at 10:00, 17 minutes ago Porsche AG provides further insight into the three pillars of Strategy 2035
Published on 06/23/2026 at 09:00, 1 hour 17 minutes ago Hong Kong unlocks new opportunities with Central Asia
Published on 06/22/2026 at 18:00, 16 hours 17 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION
